NCT05099666 2026-04-13Lurbinectedin + Doxorubicin In LeiomyosarcomaMassachusetts General HospitalPhase 1/2 Active not recruiting62 enrolled
NCT04802174 2026-03-17Lurbinectedin With Berzosertib, an ATR Kinase Inhibitor in Small Cell Cancers and High-Grade Neuroendocrine CancersNational Institutes of Health Clinical Center (CC)Phase 1/2 Active not recruiting37 enrolled